Nifoxipam is a synthetic depressant substance of the benzodiazepine chemical class that produces long-lived, typical benzodiazepine effects such as anxiety suppression, disinhibition, anticonvulsant, hypnotic, muscle relaxing, and amnesia when administered.
Nifoxipam has potential use for the short-term treatment of anxiety, insomnia, acute seizures, and the sedation of hospitalized patients.
Due to the high dependence-forming and addiction potential that this substance shares with members of the closely related benzodiazepine class, as well as its alcohol-like ability to induce dangerous disinhibitory black-out states, it is highly advised to use proper harm reduction practices if choosing to use this substance.
Nifoxipam is a drug of the benzodiazepine class. Benzodiazepine drugs contain a benzene ring fused to a diazepine ring, which is a seven membered ring with the two nitrogen constituents located at R1 and R4. Nifoxipam, or 3-hydroxydesmethylflunitrazepam, is an active metabolite of flunitrazepam.
Benzodiazepines produce a variety of effects by binding to the benzodiazepine receptor site and magnifying the efficiency and effects of the neurotransmitter gamma aminobutyric acid (GABA) by acting on its receptors.
Motor control loss
Nifoxipam is sold for research purposes only and is not be utilized for any other purposes.